A 32-year-old healthy woman presents to the clinic for a routine health maintenance examination. She has no significant past medical history. During the visit, she expresses concern about her cancer risk because her mother was diagnosed with bilateral breast cancer at age 46, and her maternal aunt was diagnosed with ovarian cancer at age 52. The patient has not undergone any previous genetic evaluation. According to the United States Preventive Services Task Force (USPSTF) guidelines, arrange the following steps in the correct clinical and chronological sequence for the management of this patient's familial cancer risk, from the immediate next step in the primary care clinic to long-term management.
- 1Administer a validated brief familial risk assessment tool (e.g., Ontario Family History Assessment Tool).
- 2Refer the patient to a specialized provider for formal genetic counseling.
- 3Perform targeted genetic testing for BRCA1 and BRCA2 pathogenic variants.
- 4Initiate enhanced breast cancer surveillance with an annual magnetic resonance imaging (MRI) scan.
- 5Counsel the patient regarding risk-reducing bilateral salpingo-oophorectomy after completion of childbearing.
Answer
The correct sequence begins with primary care risk stratification using a brief familial risk assessment tool, followed by referral for genetic counseling, genetic testing, initiation of enhanced MRI screening, and finally, consideration of risk-reducing prophylactic surgery.
The correct sequence strictly follows the USPSTF Grade B recommendation for BRCA-related cancer risk assessment. The pathway mandates starting with a brief familial risk assessment tool in the primary care setting. If positive, this is followed by a referral for formal genetic counseling. Only after counseling is genetic testing performed. If a pathogenic variant is confirmed, the patient is transitioned to a high-risk management protocol, which begins with enhanced surveillance (e.g., annual MRI) and eventually includes risk-reducing prophylactic surgeries after childbearing is complete.
Step-by-Step Solution
Key Concept
The USPSTF guidelines for BRCA1/2-related cancer screening mandate a stepwise cascade: Brief Risk Assessment Tool → Genetic Counseling → Genetic Testing → Targeted Surveillance → Prophylactic Interventions.